Skip to main content

AGR2 Expression is Regulated by HIF-1 and Contributes to Growth and Angiogenesis of Glioblastoma

Cell Biochemistry and Biophysics volume 67, pages 1487–1495 (2013)Cite this article

Abstract

Glioblastoma multiforme (GBM) tumors are the most common type of brain tumors characterized by extensive angiogenesis that is mostly orchestrated by tumor hypoxia. The hypoxia induced factor-1 (HIF-1) transcriptional complex is the “master control switch” for hypoxia. Dysregulation of anterior gradient protein 2 (AGR2) expression is associated with tumor growth and metastasis. Whether AGR2 is a hypoxia-responsive factor and affects tumor progression via angiogenesis remains unknown. Here, we show that GBM cell lines, U87 and LN18, exhibited enhanced hypoxic responses compared with control normal human astrocytes, and a corresponding HIF-1-dependent increase in AGR2 mRNA and protein. Recombinant AGR2 and conditioned medium from GBM cells induced human umbilical vein endothelial cell (HUVEC) migration and tube formation, which were abrogated by anti-AGR2 neutralizing antibodies. Expression of the HIF-1α oxygen-dependent degradation domain mutant in cells resulted in elevated AGR2 levels and an increased ability to induce HUVEC migration and tube formation in vitro and enhanced growth and vascularity of tumor xenografts in vivo, which were prevented by AGR2 knockdown. Taken together, these results indicate that AGR2 expression is regulated by HIF-1 and plays an important role in control of glioblastoma growth and vascularity. Our findings suggest that inhibiting AGR2 may represent a new therapeutic target for anti-angiogenic cancer treatment.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

References

  1. Zhao, N., Sun, B. C., Sun, T., Ma, Y. M., Zhao, X. L., Liu, Z. Y., et al. (2012). Hypoxia-induced vasculogenic mimicry formation via VE-cadherin regulation by Bcl-2. Medical Oncology, 29(5), 3599–3607.

    PubMed  Article  CAS  Google Scholar 

  2. Facciabene, A., Peng, X., Hagemann, I. S., Balint, K., Barchetti, A., Wang, L. P., et al. (2011). Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells. Nature, 475(7355), 226–230.

    PubMed  Article  CAS  Google Scholar 

  3. Oliver, L., Olivier, C., Marhuenda, F. B., Campone, M., & Vallette, F. M. (2009). Hypoxia and the malignant glioma microenvironment: regulation and implications for therapy. Current Molecular Pharmacology, 2(3), 263–284.

    PubMed  Article  CAS  Google Scholar 

  4. Wang, G. L., & Semenza, G. L. (1995). Purification and characterization of hypoxia-inducible factor 1. Journal of Biological Chemistry, 270(3), 1230–1237.

    PubMed  Article  CAS  Google Scholar 

  5. Tanimoto, K., Makino, Y., Pereira, T., & Poellinger, L. (2000). Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. EMBO Journal, 19(16), 4298–4309.

    PubMed  Article  CAS  Google Scholar 

  6. Vajkoczy, P., Farhadi, M., Gaumann, A., Heidenreich, R., Erber, R., Wunder, A., et al. (2002). Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2. Journal of Clinical Investigation, 109(6), 777–785.

    PubMed  CAS  Google Scholar 

  7. Fiorenzo, P., Mongiardi, M. P., Dimitri, D., Cozzolino, M., Ferri, A., Montano, N., et al. (2010). HIF1-positive and HIF1-negative glioblastoma cells compete in vitro but cooperate in tumor growth in vivo. International Journal of Oncology, 36(4), 785–791.

    PubMed  CAS  Google Scholar 

  8. Miletic, H., Niclou, S. P., Johansson, M., & Bjerkvig, R. (2009). Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms. Expert Opinion on Therapeutic Targets, 13(4), 455–468.

    PubMed  Article  CAS  Google Scholar 

  9. Thompson, D. A., & Weigel, R. J. (1998). hAG-2, the human homologue of the Xenopus laevis cement gland gene XAG-2, is coexpressed with estrogen receptor in breast cancer cell lines. Biochemical and Biophysical Research Communications, 251(1), 111–116.

    PubMed  Article  CAS  Google Scholar 

  10. Komiya, T., Tanigawa, Y., & Hirohashi, S. (1999). Cloning of the gene gob-4, which is expressed in intestinal goblet cells in mice. Biochimica et Biophysica Acta, 1444(3), 434–438.

    PubMed  Article  CAS  Google Scholar 

  11. Aberger, F., Weidinger, G., & Grunz, H. (1998). Anterior specification of embryonic ectoderm: The role of the Xenopus cement gland-specific gene XAG-2. Mechanisms of Development, 72(1–2), 115–130.

    PubMed  Article  CAS  Google Scholar 

  12. Liu, D., Rudland, P. S., Sibson, D. R., Platt-Higgins, A., & Barraclough, R. (2005). Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas. Cancer Research, 65(9), 3796–3805.

    PubMed  Article  CAS  Google Scholar 

  13. Fritzsche, F. R., Dahl, E., Pahl, S., Burkhardt, M., Luo, J., Mayordomo, E., et al. (2006). Prognostic relevance of AGR2 expression in breast cancer. Clinical Cancer Research, 12(6), 1728–1734.

    PubMed  Article  CAS  Google Scholar 

  14. Innes, H. E., Liu, D., Barraclough, R., Davies, M. P., O’Neill, P. A., Platt-Higgins, A., et al. (2006). Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients. British Journal of Cancer, 94(7), 1057–1065.

    PubMed  Article  CAS  Google Scholar 

  15. Groome, M., Lindsay, J., Ross, P. E., Cotton, J. P., Hupp, T. R., & Dillon, J. F. (2008). Use of oesophageal stress response proteins as potential biomarkers in the screening for Barrett’s oesophagus. European Journal of Gastroenterology and Hepatology, 20(10), 961–965.

    PubMed  Article  CAS  Google Scholar 

  16. Wang, Z., Hao, Y., & Lowe, A. W. (2008). The adenocarcinoma-associated antigen, AGR2, promotes tumor growth, cell migration, and cellular transformation. Cancer Research, 68(2), 492–497.

    PubMed  Article  CAS  Google Scholar 

  17. Ramachandran, V., Arumugam, T., Wang, H., & Logsdon, C. D. (2008). Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival. Cancer Research, 68(19), 7811–7818.

    PubMed  Article  CAS  Google Scholar 

  18. Zhu, H., Lam, D. C., Han, K. C., Tin, V. P., Suen, W. S., Wang, E., et al. (2007). High resolution analysis of genomic aberrations by metaphase and array comparative genomic hybridization identifies candidate tumour genes in lung cancer cell lines. Cancer Letters, 245(1–2), 303–314.

    PubMed  Article  CAS  Google Scholar 

  19. Zhang, Y., Ali, T. Z., Zhou, H., D’Souza, D. R., Lu, Y., Jaffe, J., et al. (2010). ErbB3 binding protein 1 represses metastasis-promoting gene anterior gradient protein 2 in prostate cancer. Cancer Research, 70(1), 240–248.

    PubMed  Article  CAS  Google Scholar 

  20. Pohler, E., Craig, A. L., Cotton, J., Lawrie, L., Dillon, J. F., Ross, P., et al. (2004). The Barrett’s antigen anterior gradient-2 silences the p53 transcriptional response to DNA damage. Molecular and Cellular Proteomics, 3(6), 534–547.

    PubMed  Article  CAS  Google Scholar 

  21. Kissler, S., Stern, P., Takahashi, K., Hunter, K., Peterson, L. B., & Wicker, L. S. (2006). In vivo RNA interference demonstrates a role for Nramp1 in modifying susceptibility to type 1 diabetes. Nature Genetics, 38(4), 479–483.

    PubMed  Article  CAS  Google Scholar 

  22. Forsythe, J. A., Jiang, B. H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., et al. (1996). Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Molecular and Cellular Biology, 16(9), 4604–4613.

    PubMed  CAS  Google Scholar 

  23. Ke, Q., & Costa, M. (2006). Hypoxia-inducible factor-1 (HIF-1). Molecular Pharmacology, 70(5), 1469–1480.

    PubMed  Article  CAS  Google Scholar 

  24. Mercapide, J., Lopez De Cicco, R., Castresana, J. S., & Klein-Szanto, A. J. (2003). Stromelysin-1/matrix metalloproteinase-3 (MMP-3) expression accounts for invasive properties of human astrocytoma cell lines. International Journal of Cancer, 106(5), 676–682.

    Article  CAS  Google Scholar 

  25. Reardon, D. A., Turner, S., Peters, K. B., Desjardins, A., Gururangan, S., Sampson, J. H., et al. (2011). A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastoma. Journal of the National Comprehensive Cancer Network, 9(4), 414–427.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We are thankful to Dr. Min Zhang (The University of Hong Kong) for luciferase reporter plasmids containing the wild-type or mutated VEGF promoter, and the HIF-1α oxygen-dependent degradation domain mutant lentivirus.

Conflict of interest

We have no conflict of interest to declare and informed consent was obtained.

Author information

Affiliations

  1. Department of Vascular Surgery, China–Japan Union Hospital Affiliated to Jilin University, Changchun, 130031, China

    Xing-Yu Hong

  2. School of Life Sciences, Jilin Agricultural University, Changchun, 130118, China

    Jing Wang

  3. Department of Cardiovascular Surgery, China-Japan Union Hospital Affiliated to Jilin University, Changchun, 130031, China

    Zhe Li

Authors
  1. Xing-Yu Hong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jing Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhe Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhe Li.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hong, XY., Wang, J. & Li, Z. AGR2 Expression is Regulated by HIF-1 and Contributes to Growth and Angiogenesis of Glioblastoma. Cell Biochem Biophys 67, 1487–1495 (2013). https://doi.org/10.1007/s12013-013-9650-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-013-9650-4

Keywords

  • Glioblastom Multiforme
  • Anterior gradient protein 2
  • Hypoxia
  • Hypoxia induced factor-1
  • Tumor angiogenesis